Overview

A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

Status:
Completed
Trial end date:
2020-06-03
Target enrollment:
Participant gender:
Summary
Phase 4 clinical trial to Evaluate the blood pressure lowering effect of a Candesartan/Hydrochlorothiazide(Candemore Plus Tab) versus Candesartan/Amlodipine(Cantabell Tab) in Hypertensive Patients
Phase:
Phase 4
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical